124 related articles for article (PubMed ID: 36043900)
1. Outcomes of extensive stage extrapulmonary small cell cancer.
Gandy G; Yip PY; Tognela A; Hayat F; Fox W; Kok PS
Intern Med J; 2023 Sep; 53(9):1556-1563. PubMed ID: 36043900
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the outcomes of pulmonary versus extrapulmonary extensive-stage small cell carcinoma.
Chen E; Yip PY; Tognela A; Gandy G; Earl C; Tran P; Kok PS
Intern Med J; 2024 Mar; 54(3):414-420. PubMed ID: 38009656
[TBL] [Abstract][Full Text] [Related]
3. Extrapulmonary small cell carcinoma: single center experience with 61 patients.
Lee SS; Lee JL; Ryu MH; Chang HM; Kim TW; Kim WK; Lee JS; Jang SJ; Khang SK; Kang YK
Acta Oncol; 2007; 46(6):846-51. PubMed ID: 17653910
[TBL] [Abstract][Full Text] [Related]
4. Should patients with extrapulmonary small-cell carcinoma receive prophylactic cranial irradiation?
Naidoo J; Teo MY; Deady S; Comber H; Calvert P
J Thorac Oncol; 2013 Sep; 8(9):1215-21. PubMed ID: 23945390
[TBL] [Abstract][Full Text] [Related]
5. Retrospective review of extra-pulmonary small cell carcinoma and prognostic factors.
Brammer JE; Lulla P; Lynch GR
Int J Clin Oncol; 2014 Oct; 19(5):822-8. PubMed ID: 24122253
[TBL] [Abstract][Full Text] [Related]
6. Extrapulmonary small cell carcinoma: Prognostic factors, patterns of care, and overall survival.
Mandish SF; Gaskins JT; Yusuf MB; Little BP; Dunlap NE
Eur J Surg Oncol; 2020 Sep; 46(9):1596-1604. PubMed ID: 32336623
[TBL] [Abstract][Full Text] [Related]
7. Extrapulmonary Small Cell Cancer: A New Insight into a Rare Disease.
Brazg Ferro L; Wolf I; Peleg Hasson S; Golomb I; Osher E; Berlin A; Gutfeld O; Ospovat I; Soyfer V
Oncology; 2021; 99(6):373-379. PubMed ID: 33774637
[TBL] [Abstract][Full Text] [Related]
8. [First-line chemotherapy and its survival analysis of 394 patients with extensive-stage small cell lung cancer in a single institute].
Ma M; Wang M; Xu Y; Hu K; Liu H; Li L; Zhong W; Zhang L; Zhao J; Wang H
Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):8-14. PubMed ID: 24398308
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
Fukui T; Itabashi M; Ishihara M; Hiyoshi Y; Kasajima M; Igawa S; Sasaki J; Masuda N
BMC Cancer; 2016 Mar; 16():197. PubMed ID: 26955807
[TBL] [Abstract][Full Text] [Related]
10. Retrospective review of extra-pulmonary small cell carcinoma at King Chulalongkorn memorial hospital cases during 1998-2005.
Chalermchai T; Suwanrusme H; Chantranuwat P; Voravud N; Sriuranpong V
Asia Pac J Clin Oncol; 2010 Jun; 6(2):111-5. PubMed ID: 20565423
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of pretreatment lung immune prognostic index in extensive-stage small-cell lung cancer treated with platinum plus etoposide chemotherapy.
Qi W; Zhao S; Chen J
Cancer Biomark; 2021; 31(2):177-185. PubMed ID: 33896825
[TBL] [Abstract][Full Text] [Related]
12. Extrapulmonary small cell carcinoma (EPSCC): 10 years' multi-disciplinary experience at Charité.
Ochsenreither S; Marnitz-Schultze S; Schneider A; Koehler C; Daum S; Loddenkemper C; Budach V; Thiel E; Keilholz U; Schmittel A
Anticancer Res; 2009 Aug; 29(8):3411-5. PubMed ID: 19661365
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factor analysis of patients with small cell lung cancer: Real-world data from 988 patients.
Ma X; Zhang Z; Chen X; Zhang J; Nie J; Da L; Hu W; Tian G; Wu D; Han J; Han S; Long J; Wang Y; Fang J
Thorac Cancer; 2021 Jun; 12(12):1841-1850. PubMed ID: 33955685
[TBL] [Abstract][Full Text] [Related]
14. Extrapulmonary small-cell carcinoma: a single-institution experience.
Kim JH; Lee SH; Park J; Kim HY; Lee SI; Nam EM; Park JO; Kim K; Jung CW; Im YH; Kang WK; Lee MH; Park K
Jpn J Clin Oncol; 2004 May; 34(5):250-4. PubMed ID: 15231859
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations.
Han J; Fu C; Li B
Radiat Oncol; 2021 Mar; 16(1):47. PubMed ID: 33663551
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970-2004.
Wong YN; Jack RH; Mak V; Henrik M; Davies EA
BMC Cancer; 2009 Jun; 9():209. PubMed ID: 19563623
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and survival of extrapulmonary small cell carcinoma in 11 different primary tumor sites in the United States, 1975-2016.
Xu JL; Guo Y
Curr Med Res Opin; 2021 Jan; 37(1):71-81. PubMed ID: 33135938
[TBL] [Abstract][Full Text] [Related]
18. The prognostic values of prognostic nutritional index in extensive-stage small-cell lung cancer.
Bahçeci A; Kötek Sedef A; Işik D
Anticancer Drugs; 2022 Jan; 33(1):e534-e540. PubMed ID: 34407045
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
Koch A; Fohlin H; Sörenson S
J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
[TBL] [Abstract][Full Text] [Related]
20. Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma: a retrospective single-center study.
Cicin I; Karagol H; Uzunoglu S; Uygun K; Usta U; Kocak Z; Caloglu M; Saynak M; Tokatli F; Uzal C
Cancer; 2007 Sep; 110(5):1068-76. PubMed ID: 17614337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
